NDC 71591-011

This exact product or package identity exists in FDA auxiliary data but is not present in the current primary NDC product table. The package identity is preserved; status rows are reported source observations, not medical conclusions.

Requested NDC: 71591-011
Product root: 71591-011
Identity scope: Product
Primary current NDC product row: Not present

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
compounder	package	71591-011	71591-011-60	COMPOUNDER	Outsourcing facility compounded drug report	2019-2	2026-10-15
compounder	package	71591-011	71591-011-30	COMPOUNDER	Outsourcing facility compounded drug report	2019-2	2026-10-15
compounder	package	71591-011	71591-011-30	COMPOUNDER	Outsourcing facility compounded drug report	2019-1	2026-10-15
compounder	package	71591-011	71591-011-60	COMPOUNDER	Outsourcing facility compounded drug report	2019-1	2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 4 matching rows.

View current auxiliary records. · View the auxiliary file history.

Package NDC, Reporting period table
Package NDC	Reporting period
71591-011-60	2019-2
71591-011-30	2019-2
71591-011-60	2019-1
71591-011-30	2019-1

Compounder NDC reports#

Browse the complete compounder directory for this NDC · Browse every current compounder row in the unified auxiliary catalog · browse compounder source captures and parsed snapshots.

Establishment, FEI, Product NDC table
Establishment	Product NDC	Package NDC	Product	Active ingredients	Reporting period	Normalization
"Atlas Pharmaceuticals, LLC(057234359)"	71591-011	71591-011-30	Buprenorphine Hydrochloride	.6 mg/1 mL	2019-2	valid
"Atlas Pharmaceuticals, LLC(057234359)"	71591-011	71591-011-60	Buprenorphine Hydrochloride	.6 mg/1 mL	2019-2	valid
"Atlas Pharmaceuticals, LLC(057234359)"	71591-011	71591-011-30	Buprenorphine Hydrochloride	.6 mg/1 mL	2019-1	valid
"Atlas Pharmaceuticals, LLC(057234359)"	71591-011	71591-011-60	Buprenorphine Hydrochloride	.6 mg/1 mL	2019-1	valid

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.